Insiders Advisor
  • Stocks
  • World News
  • Business
  • Politics
  • Stocks
  • World News
  • Business
  • Politics

Insiders Advisor

Business

CVS replaces CEO as profits, share price suffer

by October 19, 2024
October 19, 2024
CVS replaces CEO as profits, share price suffer

Longtime CVS Health executive David Joyner has replaced Karen Lynch as CEO, as the company struggles to drive higher profits and stock performance, CVS announced Friday.

The move, effective Thursday, the day before the announcement, comes as CVS shares have fallen nearly 20% this year. Shares plunged about 13% in premarket trading Friday.

CVS has faced challenges as higher medical costs weigh on its insurance unit, Aetna, and consumer spending drops at its retail pharmacies. In August, the company slashed its full-year profit guidance and said it would cut $2 billion in costs over the next several years.

In its release Friday, CVS also said it expects adjusted earnings of between $1.05 and $1.10 per share in its third quarter. It anticipates higher medical costs than previously expected, with a so-called medical benefit ratio of 95.2% in the quarter.

“In light of continued elevated medical cost pressures in the Health Care Benefits segment, investors should no longer rely on the Company’s previous guidance provided on its second quarter 2024 earnings call on August 7, 2024,” CVS said in the release.

The company is set to report third-quarter earnings on Nov. 6.

Last month, major CVS shareholder Glenview Capital began a significant push for changes at the company, CNBC previously reported.

CNBC reported last month that CVS’ board had engaged strategic advisors to weigh its options, including the potential of a breakup of its insurance and retail businesses.

Joyner most recently oversaw the company’s pharmacy services business as president of CVS Caremark, a similar position to the one Lynch held before she assumed the top job in February 2021. He began his career at Aetna in pharmacy benefit services and previously held the role of executive vice president of sales and marketing at CVS Health.

“We believe David and his deep understanding of our integrated business can help us more directly address the challenges our industry faces, more rapidly advance the operational improvements our company requires, and fully realize the value we can uniquely create,” Chairman Roger Farah said in a statement.

Lynch also stepped down from the company’s board of directors this week, the company said Friday. Joyner will take a seat on the board, and Farah will assume the role of executive chairman.

This post appeared first on NBC NEWS
previous post
Biden’s gone silent on Ukraine support, ranking member of Armed Services Committee warns
next post
Week Ahead: NIFTY May Stay Ranged; Trending Moves To Occur Only If These Edges Are Breached

Related Posts

About 800,000 BetterHelp online therapy customers receive refund...

May 11, 2024

Willow Bay and Bob Iger to take controlling...

July 18, 2024

Lara Trump to host weekend show on Fox...

February 6, 2025

Target lowering prices on 5,000 frequently bought items

May 21, 2024

Peacock raising prices by $2 ahead of the...

April 30, 2024

Nissan issues ‘do not drive’ warning for 84,000...

May 31, 2024

Boeing machinists reject new labor contract, extending strike

October 25, 2024

Fed minutes point to ‘likely’ rate cut coming...

August 22, 2024

GM’s 2025 EV production capacity target in doubt...

July 17, 2024

Chinese tea chain Chagee files for U.S. initial...

March 27, 2025

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Latest News

    • ‘Bait and switch’: Schumer warns of bitter funding fight over GOP cuts plan

      July 8, 2025
    • New book exposes Jill Biden’s power grab amid husband’s political demise

      July 8, 2025
    • DeSantis not keen on Musk’s new political party, has another idea for disrupting DC

      July 8, 2025
    • US will ‘have to’ send weapons to Ukraine, Trump says days after Pentagon pause

      July 8, 2025
    • Key advisor called Hunter Biden’s role on strategy call ‘inappropriate’ after he overruled legal guidance

      July 8, 2025
    • Former Biden doctor asks to delay testimony to House committee investigating mental fitness

      July 8, 2025

    Categories

    • Business (1,296)
    • Politics (6,304)
    • Stocks (904)
    • World News (460)
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: insidersadvisor.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 insidersadvisor.com | All Rights Reserved